Kiniksa Pharmaceuticals
KNSA
KNSA
96 hedge funds and large institutions have $306M invested in Kiniksa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 20 closing their positions.
Holders
96
Holders Change
-7
Holders Change %
-6.8%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
13
Increased
36
Reduced
30
Closed
20
Calls
$2.44M
Puts
$1.77M
Net Calls
+$667K
Net Calls Change
-$207K
Top Buyers
| 1 |
GPP
1
Great Point Partners
Greenwich,
Connecticut
|
$11.1M |
| 2 |
TCM
2
Tang Capital Management
San Diego,
California
|
$4.97M |
| 3 |
3
Millennium Management
New York
|
$9.82M |
| 4 |
LPC
4
Lion Point Capital
New York
|
$4.77M |
| 5 |
5
Goldman Sachs
New York
|
$9.31M |
